1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Oregon >
  6. JSR Acquires Inpria

M&A Deal Summary

JSR Acquires Inpria

On September 17, 2021, JSR acquired semiconductors company Inpria for 514M USD

Acquisition Highlights
  • This is JSR’s 1st transaction in the Semiconductors sector.
  • This is JSR’s 2nd largest (disclosed) transaction.
  • This is JSR’s 1st transaction in the United States.
  • This is JSR’s 1st transaction in Oregon.

M&A Deal Summary
Date 2021-09-17
Target Inpria
Sector Semiconductors
Buyer(s) JSR
Deal Type Add-on Acquisition
Deal Value 514M USD

Target

Inpria

Corvallis, Oregon, United States
Inpria is a provider of metal oxide photoresist design, development, and manufacturing. Inpria’s EUV photoresists enable semiconductor manufacturers to realize the full potential of EUV lithography. Inpria is based in Corvallis, Oregon.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

JSR

Tokyo, Japan
Category Company
Founded 1948
Sector Chemicals
Employees9,278
Revenue 408.9B JPY (2023)
DESCRIPTION

JSR engages in production and sale of petrochemicals, synthetic rubbers, and emulsions. It applies its polymer technology for production of photo-chemicals and organic synthesis-chemicals. JSR was founded in 1948 and is based in Tokyo, Japan.

DEAL STATS #
Overall 4 of 4
Sector: Semiconductors M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 2
State: Oregon M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2021 M&A 1 of 1
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-12-20 Crown Bioscience International

Taipei, Taiwan

Crown Bioscience International is a software solutions company discovery and drug development, providing translational platforms to advance research into oncology, inflammation, and cardiovascular and metabolic diseases.

Buy $12.0B
Mergr

Solution for

Product

Company

Legal